These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics. Kumar D; Gupta A; Mandhani A; Sankhwar SN Prostate; 2016 Sep; 76(12):1106-19. PubMed ID: 27197810 [TBL] [Abstract][Full Text] [Related]
64. Predictive value of cyclooxygenase-2 over expression for identifying prostate cancer from benign prostatic hyperplasia in prostate biopsy specimens. Ceylan Y; Lekili M; Muezzinoglu T; Nese N; Isisag A Minerva Urol Nefrol; 2016 Jun; 68(3):255-62. PubMed ID: 26125280 [TBL] [Abstract][Full Text] [Related]
65. [1H magnetic resonance spectroscopy of the prostate]. Mueller-Lisse UG; Scherr M Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263 [TBL] [Abstract][Full Text] [Related]
66. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978 [TBL] [Abstract][Full Text] [Related]
68. Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci. Sciarra A; Panebianco V; Salciccia S; Gentilucci A; Alfarone A; Dimare L; Lisi D; Catturino S; Di Pierro G; Von Heland M; Ciccariello M; Passariello R; Gentile V Urol Oncol; 2011; 29(6):634-40. PubMed ID: 19914107 [TBL] [Abstract][Full Text] [Related]
69. [Application value of diagnostic TURP for patients with serum PSA abnormality]. Yuan J; Zhao H; Wu B Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094 [TBL] [Abstract][Full Text] [Related]
70. A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Bell JD; Cox IJ; Sargentoni J; Peden CJ; Menon DK; Foster CS; Watanapa P; Iles RA; Urenjak J Biochim Biophys Acta; 1993 Nov; 1225(1):71-7. PubMed ID: 8241291 [TBL] [Abstract][Full Text] [Related]
71. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection. Kline EE; Treat EG; Averna TA; Davis MS; Smith AY; Sillerud LO J Urol; 2006 Nov; 176(5):2274-9. PubMed ID: 17070311 [TBL] [Abstract][Full Text] [Related]
72. Detection of prostate cancer by an electronic nose: a proof of principle study. Roine A; Veskimäe E; Tuokko A; Kumpulainen P; Koskimäki J; Keinänen TA; Häkkinen MR; Vepsäläinen J; Paavonen T; Lekkala J; Lehtimäki T; Tammela TL; Oksala NK J Urol; 2014 Jul; 192(1):230-4. PubMed ID: 24582536 [TBL] [Abstract][Full Text] [Related]
73. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. Benson MC; Whang IS; Pantuck A; Ring K; Kaplan SA; Olsson CA; Cooner WH J Urol; 1992 Mar; 147(3 Pt 2):815-6. PubMed ID: 1371554 [TBL] [Abstract][Full Text] [Related]
74. Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer. Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R Tunis Med; 2013 Jul; 91(7):458-63. PubMed ID: 24008878 [TBL] [Abstract][Full Text] [Related]
75. High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence. Tayari N; Steinseifer IK; Selnæs KM; Bathen TF; Maas MC; Heerschap A Invest Radiol; 2017 Oct; 52(10):640-646. PubMed ID: 28632688 [TBL] [Abstract][Full Text] [Related]
76. Atypical adenomatous hyperplasia of the prostate mimicking adenocarcinoma lesion: case report and literature review. Enciu M; Aşchie M; Boşoteanu M; Chisoi A Rom J Morphol Embryol; 2012; 53(4):1093-6. PubMed ID: 23303039 [TBL] [Abstract][Full Text] [Related]
77. The value of ESWAN in diagnosis and differential diagnosis of prostate cancer: Preliminary study. Xin JY; Gao SS; Liu JG; Sun CF; Han Y; Sun XH; Wang XZ; Wang B Magn Reson Imaging; 2017 Dec; 44():26-31. PubMed ID: 28782677 [TBL] [Abstract][Full Text] [Related]
78. Discrepancies between findings suspicious for prostate cancer at rectal examination and benign biopsy findings. Epstein JI Radiology; 1993 Dec; 189(3):657-8. PubMed ID: 7694309 [No Abstract] [Full Text] [Related]
79. Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia. Sciarra A; Gentile V; Monti S; Dattilo C; Autran Gomez A; Salciccia S; Pannunzi LP; Toscano V; Di Silverio F Urol Int; 2008; 80(1):68-73. PubMed ID: 18204237 [TBL] [Abstract][Full Text] [Related]
80. In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate gland by magnetic resonance imaging. Kjaer L; Thomsen C; Iversen P; Henriksen O Magn Reson Imaging; 1987; 5(1):23-30. PubMed ID: 2438532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]